Ординатура / Офтальмология / Английские материалы / Shields Textbook of Glaucoma, 6th edition_Allingham, Damji, Freedman_2010

57.Pohjola S, Horsmanheimo A. Topically applied corticosteroids in glaucoma capsulare. Arch Ophthalmol. 1971;85(2):150-153.

58.Gillies WE. Corticosteroid-induced ocular hypertension in pseudoexfoliation of lens capsule. Am J Ophthalmol. 1970;70(1):90-95.

59.Liu Y, Schmidt S, Qin X, et al. Lack of association between LOXL1 variants and primary openangle glaucoma in three different populations. Invest Ophthalmol Vis Sci. 2008;49(8):3465-3468.

60.Lindblom B, Thorburn W. Functional damage at diagnosis of primary open angle glaucoma. Acta Ophthalmol. 1984;62(2):223-229.

61.Futa R, Shimizu T, Furuyoshi N, et al. Clinical features of capsular glaucoma in comparison with primary open-angle glaucoma in Japan. Acta Ophthalmol. 1992;70(2):214-219.

62.Olivius E, Thorburn W. Prognosis of glaucoma simplex and glaucoma capsulare. A comparative study. Acta Ophthalmol. 1978;56(6):921-934.

63.Puska P, Raitta C. Exfoliation syndrome as a risk factor for optic disc changes in nonglaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 1992;230(6):501-504.

64.Tezel G, Tezel TH. The comparative analysis of optic disc damage in exfoliative glaucoma. Acta Ophthalmol. 1993;71(6):744-750.

65.Netland PA, Ye H, Streeten BW, et al. Elastosis of the lamina cribrosa in exfoliation syndrome with glaucoma. Ophthalmology. 1995; 102(6):878-886.

66.Gillies WE, West RH. Exfoliation of the lens capsule and glaucoma. Aust J Ophthalmol. 1977;5:18-

67.Naumann GOH. Pathologie des Auges. Vol 2. 2nd ed. Berlin: Springer; 1997:1264.

68.Dark AJ, Streeten BW, Cornwall CC. Pseudoexfoliative disease of the lens: a study in electron microscopy and histochemistry. Br J Ophthalmol. 1977;61(7):462-472.

69.Davanger M. The pseudo-exfoliation syndrome. A scanning electron microscopic study. I. The anterior lens surface. Acta Ophthalmol. 1975; 53(6):809-820.

70.Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397-1400.

71.Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36(2):178-182.

P.261

72.Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with exfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet. 2008;17(5):710-716.

73.Challa P, Schmidt S, Liu Y, et al. Analysis of LOXL1 polymorphisms in a United States population with exfoliation glaucoma. Mol Vis. 2008;14:146-149.

74.Streeten BW, Bookman L, Ritch R, et al. Pseudoexfoliative fibrillopathy in the conjunctiva. A relation to elastic fibers and elastosis. Ophthalmology. 1987;94(11):1439-1449.

75.Schlotzer-Schrehardt U, Kuchle M, Naumann GOH. Electronmicroscopic identification of exfoliation material in extrabulbar tissue. Arch Ophthalmol. 1991;109(4):565-570.

76.Prince AM, Streeten BW, Ritch R, et al. Preclinical diagnosis of exfoliation syndrome. Arch Ophthalmol. 1987;105(8):1076-1082.

77.Schlotzer-Schrehardt UM, Koca MR, Naumann GOH, et al. Exfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110(12):1752-1756.

78.Streeten BW, Li ZY, Wallace RN, et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with exfoliation syndrome. Arch Ophthalmol. 1992;110(12):1757-1762.

79.Tsukahara S, Matsuo T. Secondary glaucoma accompanied with primary familial amyloidosis. Ophthalmologica. 1977;175(5):250-262.

80.Schwartz MF, Green WR, Michels RG, et al. An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis. Ophthalmology. 1982;89(4):394-401.

81.Silva-Araujo AC, Tavares MA, Cotta JS, et al. Aqueous outflow system in familial amyloidotic

polyneuropathy, Portuguese type. Graefes Arch Clin Exp Ophthalmol. 1993;231(3):131-135.

82.Layden WE, Ritch R, King DG, et al. Combined exfoliation and pigment dispersion syndrome. Am J Ophthalmol. 1990;109(5):530-534.

83.Konstas AG, Hollo G, Irkec M, et al. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observermasked, three-centre study. Br J Ophthalmol. 2007;91 (6):757-760.

84.Threlkeld AB, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary openangle glaucoma. J Glaucoma. 1996;5(5):311-316.

85.Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol. 2006;90(12):14901494.

86.Konstas AG, Jay JL, Marshall GE, et al. Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma. Ophthalmology. 1993;100(5):619-627.

87.Damji KF, Konstas AG, Liebmann JM, et al. Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol. 2006;90 (8): 1014-1018.

88.Skuta GL, Parrish RK II, Hodapp E, et al. Zonular dialysis during extracapsular cataract extraction in exfoliation syndrome. Arch Ophthalmol. 1987;105(5):632-634.

89.Ruotsalainen J, Tarkkanen A. Capsule thickness of cataractous lenses with and without exfoliation syndrome. Acta Ophthalmol. 1987;65(4): 444-449.

90.Carpel EF. Pupillary dilation in eyes with exfoliation syndrome. Am J Ophthalmol. 1988;105 (6):692-694.

91.Raitta C, Tarkkanen A. Posterior chamber lens implantation in capsular glaucoma. Acta Ophthalmologica. 1987;65(S182):24-26.

Say thanks please

Shields > SECTION II - The Clinical Forms of Glaucoma >

16 - Glaucomas Associated with Disorders of the Corneal Endothelium

Authors: Allingham, R. Rand

Title: Shields Textbook of Glaucoma, 6th Edition Copyright ©2011 Lippincott Williams & Wilkins

> Table of Contents > SECTION II - The Clinical Forms of Glaucoma > 16 - Glaucomas Associated with Disorders of the Corneal Endothelium

16

Glaucomas Associated with Disorders of the Corneal Endothelium

In the clinical setting of glaucoma and disorders of the cornea, it is helpful to consider two categories of conditions. In the first category, there are developmental anterior segment abnormalities, acquired conditions of the cornea, or primary disorders of the corneal endothelium that occur with glaucoma. In the second category, the cornea changes are secondary to the underlying glaucoma condition. Table 16.1 summarizes these categories and the various clinical disease categories. The subject of this chapter is primary corneal endothelial disorders that are associated with glaucoma, which include iridocorneal endothelial (ICE) syndrome; posterior polymorphous corneal dystrophy (PPCD), also called posterior polymorphic dystrophy (of cornea) (PPMD); and Fuchs endothelial dystrophy. (The remaining clinical conditions are discussed in other chapters.)

Table 16.1 Glaucoma and Corneal Disorders Disorders of the Cornea Associated with Glaucoma

A.Developmental disorders (Chapter 14 )

1.Peters anomaly

2.Sclerocornea

3.Aniridia

4.Axenfeld-Rieger syndrome

B.Acquired conditions

1.Keratouveitis (Chapter 22 )

2.Trauma (Chapter 25 )

3.Full thickness or endothelial keratoplasty (Chapter 26 )

C.Primary disorders of the cornea endothelium

1.Iridocorneal endothelial syndrome

2.Posterior polymorphous corneal dystrophy

3.Fuchs endothelial dystrophy

Glaucoma with Secondary Abnormalities of the Cornea

A.Pressure-induced corneal changes

1.Epithelial and stromal edema (acute or marked IOP elevation)

2.Endothelial changes (chronic IOP elevation)

3.Haab striae (childhood glaucoma) (Chapter 13 )

B.Exfoliation-induced corneal endothelial changes (Chapter 15 )

C.Drug-induced changes in the cornea

1.Endothelial decompensation with topical carbonic anhydrase inhibitors (Chapter 31 )

2.Toxic effect to cornea epithelium (e.g., benzalkonium chloride, ß-blockers [ Chapter 29 ], miotics [Chapter 32 ])

IRIDOCORNEAL ENDOTHELIAL SYNDROME General Clinical Features and Terminology

The ICE syndrome is characterized by a primary corneal endothelial abnormality (1). Historically, three clinical variants were distinguished on the basis of changes in the iris (Table 16.2), but it is now recognized that progressive iris atrophy, Chandler syndrome, and Cogan-Reese syndrome represent a spectrum of ICE syndrome rather than distinct clinical identities. During the lifetime of a patient with ICE syndrome, the difference in clinical features may reflect the time at which the patient is seen. For example, a patient with initial findings of Chandler syndrome may later develop iris hole formation or nodules, changing the diagnosis to progressive iris atrophy or the Cogan-Reese syndrome, respectively. In other cases, however, the disease does not progress. Among the three clinical variants of ICE syndrome, Chandler syndrome appears to be the most common (2).

In general, the clinical features include presentation in early to middle adulthood, predilection for women, reduced visual acuity, pain, abnormalities of the iris, unilateral occurrence with variable amount of cornea edema but with subclinical abnormalities of the corneal endothelium in the fellow eye, anterior chamber angle abnormalities, and glaucoma (3, 4). Familial cases are rare, and there is no consistent association with systemic diseases. In

P.263

some cases, the corneal edema may occur at intraocular pressure (IOP) levels that are normal or only slightly elevated.

Major Clinical ariations

Progressive iris atrophy

Chandler syndrome Changes in the iris are mild to absent, whereas corneal edema, often at normal IOP

Figure 16.1 Slitlamp view shows the fine, beaten-silver appearance of a corneal endothelial abnormality in a patient with ICE syndrome.

In one study of 37 consecutive cases of the ICE syndrome in the United States, Chandler syndrome was the most common clinical variation, accounting for 21 cases (56%), and was characterized by more severe corneal edema despite less severe glaucoma than in the rest of the group (2). However, in a study of 60 consecutive patients with ICE syndrome in Thailand, 38 patients had Cogan-Reese syndrome, 14 had Chandler syndrome, and 8 had progressive iris atrophy (5). In both studies, glaucoma occurred, most commonly in patients with progressive iris atrophy.

Figure 16.2 A: Specular microscopy of corneal endothelium in ICE syndrome. Cell borders are obscured, resulting in loss of the normal endothelial mosaic. Note dark areas within endothelial cells. Brighter reflections are believed to be from cell borders. B: Cornea, ICE syndrome. Scanning electron microscopy demonstrates sharp demarcation between abnormal (ICE) cells with microvilli and relatively unaffected endothelial cells. (From Cockerham GC, Kenyon KR. The corneal dystrophies. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Vol 4. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:chap 16.)

Pathologic Features Changes in the Cornea

The common feature of the ICE syndrome is a corneal endothelial abnormality, which may be seen by slitlamp biomicroscopy as a “fine hammered silver” appearance of the posterior cornea, similar to that of Fuchs endothelial dystrophy (Fig. 16.1).

The findings seen on specular microscopy of the corneal endothelium are virtually pathognomonic of the ICE syndrome. The affected endothelial cells appear dark by specular microscopy except for a light central spot and a light peripheral zone with various degrees of pleomorphism in size and shape and loss of the clear hexagonal margins (Fig. 16.2) (4, 6). As discussed earlier under the clinical features, most patients who have ICE syndrome are symptomatic in one eye; however, abnormalities in the contralateral asymptomatic eye can be identified by specular microscopy.

Light microscopy of the cornea of a patient with ICE syndrome has revealed a monolayer of reduced cell density with

P.264

occasional acellular zones and multiple endothelial layers, suggesting loss of contact inhibition (7). The ICE cells undergo metaplasia taking on morphologic features of epithelial cells, such as positive immunohistochemical staining for cytokeratins that are normally expressed by epithelium rather than

endothelium (8). Some specimens have shown mononuclear inflammatory cells between the ICE cells (9), which support a proposed mechanism of viral-induced pathogenesis of ICE syndrome (as discussed later) (10).

Figure 16.3 Eye of a patient with progressive iris atrophy, a variation of ICE syndrome, with extensive hole formation in the iris. Patients typically have more marked corectopia (the pupil is in the inferior quadrant in this eye).

This metaplasia is supported by scanning electron microscopy where the ICE cells showed numerous microvilli on the apical surface, in addition to cytoplasmic tonofilaments, and indentations on the basal surface containing clumps of fibrillar collagenous material (9). Other endothelial cells showed filopodium and cytoplasmic actin filaments suggesting migration (11). Another observation was a multilayered collagenous membrane posterior to the normal prenatal and postnatal layers of the collagenous structures of the Descemet membrane (12).

Figure 16.4 In patients with Chandler syndrome, a clinical variation of ICE syndrome, the eye may have a grossly normal-appearing iris or minimal corectopia and mild peripheral iris stromal atrophy (A), or more obvious iris changes, with a distorted, displaced pupil and variable degrees of iris stromal atrophy

but no hole formation in the iris (B). Changes in the Iris

The abnormalities of the iris constitute the primary basis for initially distinguishing clinical variations within the ICE syndrome, but as mentioned earlier, it is now recognized that these represent a spectrum the disease (3). In progressive iris atrophy, the hallmark is hole formation associated with corectopia and ectropion uvea that usually occur in the direction toward the quadrant with the most prominent area of peripheral anterior synechia (Fig. 16.3) (13). There appear to be two forms of atrophic iris holes. With stretch holes, the iris is markedly thinned in the quadrant away from the direction of pupillary distortion, and the holes develop within the area that is being stretched. In other eyes, melting holes develop without associated corectopia or thinning of the iris, which is thought to occur due to ischemia of the iris based on iris angiography (14).

In Chandler syndrome, there may be no clinically appreciated iris changes or there is minimal corectopia and mild atrophy of the stroma of the iris (Fig. 16.4). In the Cogan-Reese syndrome, the iris is distinguished by pigmented, pedunculated nodules on the surface (Fig. 16.5).

Light microscopy of the iris in ICE syndrome shows a cellular membrane on the anterior surface of the iris (Fig. 16.6), which is also referred to as a retrocorneal membrane that is continuous with that seen over the anterior chamber angle in the quadrant toward which the pupil is distorted (1, 13). The nodular lesions that are characteristic of Cogan-Reese syndrome have an ultrastructure similar to that of the underlying stroma of the iris and are always surrounded by the previously described cellular membrane (15) (Fig. 16.7).

Changes in the Lens

In rare cases, the retrocorneal membrane of the ICE syndrome may grow over the anterior lens surface, simulating the anterior lens capsule, which can create confusion when performing a capsulorrhexis during cataract surgery (16). This retrocorneal membrane can also appear on the anterior surface of an intraocular lens implant (Fig. 16.8).

P.265

Figure 16.5 A: Cogan-Reese syndrome, a variation of ICE syndrome, shows ectropion uvea, some pupil distortion, and numerous dark nodules that are most prominent on the superior area of the iris stroma. B: ICE syndrome. Iris distortion and dark nodules (nevi) are present. Abnormal endothelium is often present on the iris surface. (From Cockerham GC, Kenyon KR. The corneal dystrophies. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Vol 4. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:chap 16.)

Figure 16.8 Retrocorneal membrane in ICE syndrome on the anterior surface of the intraocular lens, which was treated with an Nd:YAG anterior capsulotomy.

P.266

Figure 16.9 A: Glaucoma occurs in a large proportion of patients with the ICE syndrome. In most cases, the glaucoma is associated with peripheral anterior synechiae, which usually extend to or beyond the Schwalbe line. B: This gonioscopic image shows the high peripheral anterior synechiae, especially in the center of the view, which also reveals a broad area of ectropion uveae. (Courtesy of William A. MacIlwaine IV, MD.)

Gonioscopic Findings

Peripheral anterior synechia, usually extending to or beyond the Schwalbe line, is another clinical feature common to the ICE syndrome (Fig. 16.9). Elevated IOP usually begins as the synechiae progressively close the anterior chamber angle. However, the glaucoma does not correlate precisely with the degree of synechial closure and has been reported to occur when the entire angle was open but apparently covered by the cellular membrane (17, 18).

These angle findings were confirmed in a histology study that revealed a Descemet-like membrane with a single layer of endothelial cells extending from the peripheral cornea and covering an open anterior chamber angle in some areas or synechial closure of the angle elsewhere in the same eye (1).

Theories of Mechanism

On the basis of the clinical and histopathologic evidence discussed earlier, Campbell and colleagues (13) proposed a “membrane theory” that a primary abnorma lity of the corneal endothelium was responsible for the findings in ICE syndrome (Fig. 16.10). The etiology that leads to the corneal endothelial changes is unknown. The absence of a positive family history and the presence of the postnatal layer of Descemet membrane suggest that it is an acquired disorder.

With evidence of inflammation in some cornea histopathology specimens, a virus-mediated mechanism has been proposed (7). Another study from this group supports this virus etiology for ICE syndrome based on the presence of DNA polymerase gene products for herpes simplex that was confirmed by sequencing the product (10). Specifically, among 31 cases (25 cornea specimens from patients with ICE syndrome and 6 from patients with chronic herpetic keratitis), 16 ICE syndrome (64%) and 4 herpetic keratitis (67%) were positive for herpes simplex virus DNA, which was localized to expression in the endothelium. Control corneas (n = 15) were negative for herpes simplex. In a smaller subset of nine ICE syndrome cases, the specimens were negative for the Epstein-Barr and herpes zoster viruses. With this high (64%), specific expression of herpes simplex (i.e., negative for Epstein-Barr and zoster viruses) in the cornea endothelium of ICE syndrome specimens, it is conceivable to consider that a herpes simplexmediated infection of the cornea endothelium transforms these cells to lose contact inhibition and to transform into an epithelial-like cell. These biologically transformed cells form a proliferative cellular membrane across the anterior chamber angle, which can obstruct the trabecular meshwork, and onto the surface of the iris, which can lead to formation of peripheral anterior synechiae and to the various iris changes observed in the spectrum of progressive iris atrophy, Cogan-Reese syndrome, and Chandler syndrome.

Differential Diagnosis

There are several disorders of the cornea or iris, many of which have associated glaucoma, which can be confused with ICE syndrome. It is helpful to think of these in the following three categories: (a) endothelial disorders, (b) dissolution of the iris, and (c) nodular lesions of the iris.

Among the other corneal endothelial disorders, PPMD may be associated with glaucoma and changes of the anterior chamber angle and iris that resemble the ICE syndrome. However, the corneal abnormalities and other clinical features clearly distinguish these two spectra of disease (discussed in the next section). Specular microscopy may be helpful in distinguishing between ICE syndrome and PPMD (19). Fuchs endothelial dystrophy has changes in the cornea endothelium that are very similar to those of the ICE syndrome but none of the chamber angle or iris features of the latter condition (discussed in the last section).

In the category of dissolution of the iris, the Axenfeld-Rieger syndrome has striking clinical and histopathologic similarities to the ICE syndrome, but the congenital nature, bilaterality, and other features described in Chapter 14 help to

P.267

separate the two conditions. Some advanced cases of progressive iris atrophy might resemble aniridia, but the bilaterality of the latter disorder is a helpful differential feature (Chapter 14). Iridoschisis is characterized by separation of superficial layers of iris stroma and may be associated with glaucoma, but it is typically a disease affecting older adults (Chapter 17).